Tissue factor-induced thrombin generation in the fasting and postprandial state among elderly survivors of myocardial infarction

Thrombosis Research

Volumn 126, Issue 4, 2010, Pages 353-359

  Lekhal, Samira ^a   Børvik, Trond ^a   Brodin, Ellen ^a   Nordøy, Arne ^a   Hansen, John Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Coagulation activation; Endogenous thrombin potential (ETP); Myocardial infarction; Postprandial lipemia; Prothrombin fragment 1 + 2

Indexed keywords

BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EX VIVO STUDY; FAT TOLERANCE TEST; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; THROMBIN TIME; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION; FASTING; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MYOCARDIAL INFARCTION; POSTPRANDIAL PERIOD; THROMBIN; THROMBOPLASTIN;

EID: 77957161821     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.10.003     Document Type: Article

References (54)

1. B. Osterud, and S.I. Rapaport Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation Proc Natl Acad Sci U S A 74 12 1977 5260 5264
2. T.W. Meade, S. Mellows, M. Brozovic, G.J. Miller, R.R. Chakrabarti, and W.R. North Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study Lancet 2 8506 1986 533 537
3. J. Heinrich, L. Balleisen, H. Schulte, G. Assmann, and L.J. van de Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men Arterioscler Thromb 14 1 1994 54 59
4. S.P. Bajaj, S.I. Rapaport, and S.F. Brown Isolation and characterization of human factor VII. Activation of factor VII by factor Xa J Biol Chem 256 1 1981 253 259
5. U. Seligsohn, B. Osterud, S.F. Brown, J.H. Griffin, and S.I. Rapaport Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII J Clin Invest 64 4 1979 1056 1065
6. R. Radcliffe, A. Bagdasarian, R. Colman, and Y. Nemerson Activation of bovine factor VII by hageman factor fragments Blood 50 4 1977 611 617
7. R. Radcliffe, and Y. Nemerson Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII J Biol Chem 250 2 1975 388 395
8. G.J. Broze Jr., and J.P. Miletich Characterization of the inhibition of tissue factor in serum Blood 69 1 1987 150 155
9. P.M. Sandset, B.J. Warn-Cramer, L.V. Rao, S.L. Maki, and S.I. Rapaport Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant Proc Natl Acad Sci U S A 88 3 1991 708 712
10. E.F. Grabowski, D.B. Zuckerman, and Y. Nemerson The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions Blood 81 12 1993 3265 3270
11. P Van̈ Dreden, M Grosley, and H Cost Total and free levels of tissue factor pathway inhibitor: a risk factor in patients with factor V Leiden? Blood Coagul Fibrinolysis 10 2 1999 115 116
12. A Dahm, V vanHylckama, B Bendz, F Rosendaal, RM Bertina, and PM Sandset Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis Blood 101 11 2003 4387 4392
13. M. Saigo, S. Abe, M. Ogawa, T. Yamashita, S. Biro, and S. Minagoe Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction Thromb Haemost 86 5 2001 1197 1203
14. E.B. Smith Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis Clin Haematol 15 2 1986 355 370
15. S. Niewiarowski, and A.K. Rao Contribution of thrombogenic factors to the pathogenesis of atherosclerosis Prog Cardiovasc Dis 26 3 1983 197 222
16. E. Tremoli, M. Camera, V. Toschi, and S. Colli Tissue factor in atherosclerosis Atherosclerosis 144 2 1999 273 283
17. Y.H. Li, J.K. Teng, W.C. Tsai, L.M. Tsai, L.J. Lin, and H.R. Guo Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction J Am Coll Cardiol 33 6 1999 1543 1548
18. P. Peternel, M. Terbizan, G. Tratar, M. Bozic, D. Horvat, and B. Salobir Markers of hemostatic system activation during treatment of deep vein thrombosis with subcutaneous unfractionated or low-molecular weight heparin Thromb Res 105 3 2002 241 246
19. D. Ardissino, P.A. Merlini, K.A. Bauer, M. Galvani, F. Ottani, and F. Franchi Coagulation activation and long-term outcome in acute coronary syndromes Blood 102 8 2003 2731 2735
20. M. Soncini, P. Gasparini, M. Lorena, A. Motta, and C. Cimminiello Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke Minerva Cardioangiol 48 11 2000 349 356
21. HC Hemker, P Giesen, R AlDieri, V Regnault, E deSmed, and R Wagenvoord The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability Pathophysiol Haemost Thromb 32 5-6 2002 249 253
22. C. Mannhalter, and P. Quehenberger Laboratory methods in the haemostatic laboratory Thromb Haemost 96 5 2006 545 546
23. D.B. Zilversmit Atherogenesis: a postprandial phenomenon Circulation 60 3 1979 473 485
24. J.R. Patsch, G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, and J.K. Dunn Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state Arterioscler Thromb 12 11 1992 1336 1345
25. P.H. Groot, W.A. van Stiphout, X.H. Krauss, H. Jansen, A. vanTol, and E. vanRamshorst Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease Arterioscler Thromb 11 3 1991 653 662
26. A. Silveira, F. Karpe, M. Blomback, G. Steiner, G. Walldius, and A. Hamsten Activation of coagulation factor VII during alimentary lipemia Arterioscler Thromb 14 1 1994 60 69
27. A. Nordoy, B. Svensson, and J.B. Hansen Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia J Thromb Haemost 1 4 2003 690 697
28. A. Nordoy, K.H. Bonaa, P.M. Sandset, J.B. Hansen, and H. Nilsen Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia Arterioscler Thromb Vasc Biol 20 1 2000 259 265
29. G.J. Miller, J.C. Martin, K.A. Mitropoulos, B.E. Reeves, R.L. Thompson, and T.W. Meade Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition Atherosclerosis 86 2-3 1991 163 171
30. S. Lekhal, T. Borvik, A. Nordoy, and J.B. Hansen Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction Lipids 43 6 2008 507 515
31. M. Burstein, H.R. Scholnick, and R. Morfin Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions J Lipid Res 11 6 1970 583 595
32. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 6 1972 499 502
33. H.C. Hemker, P. Giesen, D.R. Al, V. Regnault, S.E. de, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 1 2003 4 15
34. J.H. Morrissey, B.G. Macik, P.F. Neuenschwander, and P.C. Comp Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation Blood 81 3 1993 734 744
35. M.P. Moyer, R.P. Tracy, P.B. Tracy, C. van'tVeer, C.E. Sparks, and K.G. Mann Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes Arterioscler Thromb Vasc Biol 18 3 1998 458 465
36. S. Rota, N.A. McWilliam, T.P. Baglin, and C.D. Byrne Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E Blood 91 2 1998 508 515
37. K.A. Mitropoulos, G.J. Miller, G.F. Watts, and P.N. Durrington Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency Atherosclerosis 95 2-3 1992 119 125
38. K.A. Mitropoulos, B.E. Reeves, D.P. O'Brien, J.A. Cooper, and J.C. Martin The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface Blood Coagul Fibrinolysis 4 2 1993 223 234
39. G.J. Miller, J.C. Martin, K.A. Mitropoulos, M.P. Esnouf, J.A. Cooper, and J.H. Morrissey Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency Blood 87 10 1996 4187 4196
40. A. Silveira, F. Karpe, H. Johnsson, K.A. Bauer, and A. Hamsten In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway Arterioscler Thromb Vasc Biol 16 11 1996 1333 1339
41. M. Falciani, A.M. Gori, S. Fedi, L. Chiarugi, I. Simonetti, and R.P. Dabizzi Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients Thromb Haemost 79 3 1998 495 499
42. E. Brodin, T. Borvik, P.M. Sandset, K.H. Bonaa, A. Nordoy, and J.B. Hansen Coagulation activation in young survivors of myocardial infarction (MI)-a population-based case-control study Thromb Haemost 92 1 2004 178 184
43. T. Sakata, T. Mannami, S. Baba, Y. Kokubo, K. Kario, and A. Okamoto Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries Atherosclerosis 176 2 2004 355 360
44. E. Morishita, H. Asakura, M. Saito, M. Yamazaki, Y. Ontachi, and T. Mizutani Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients Atherosclerosis 154 1 2001 203 212
45. P.B. Leurs, R. vanOerle, B.H. Wolffenbuttel, and K. Hamulyak Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus Thromb Haemost 77 3 1997 472 476
46. J.B. Hansen, K.R. Huseby, N.E. Huseby, P.M. Sandset, T.A. Hanssen, and A. Nordoy Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia Arterioscler Thromb Vasc Biol 15 7 1995 879 885
47. W.F. Novotny, M. Palmier, T.C. Wun, G.J. Broze Jr., and J.P. Miletich Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor Blood 78 2 1991 394 400
48. J.B. Hansen, K.R. Huseby, N.E. Huseby, M. Ezban, and A. Nordoy Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro Thromb Res 85 5 1997 413 425
49. C. Veer, and K.G. Mann Regulation of Tissue Factor Initiated Thrombin Generation by the Stoichiometric Inhibitors Tissue Factor Pathway Inhibitor, Antithrombin-III, and Heparin Cofactor-II J Biol Chem 272 7 1997 4367 4377
50. E. Brodin, H. Appelbom, B. Osterud, I. Hilden, L.C. Petersen, and J.B. Hansen Regulation of thrombin generation by TFPI in plasma without and with heparin Transl Res 153 3 2009 124 131
51. E. Brodin, N. Iversen, and J.B. Hansen Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase J Lab Clin Med 147 4 2006 167 173
52. R. Danielsen, P.T. Onundarson, H. Thors, B. Vidarsson, and J.H. Morrissey Activated and total coagulation factor VII, and fibrinogen in coronary artery disease Scand Cardiovasc J 32 2 1998 87 95
53. E Moor, A Silveira, F van'thooft, AM Suontaka, P Eriksson, and M Blomback Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype Arterioscler Thromb Vasc Biol 15 5 1995 655 664
54. J.A. Cooper, G.J. Miller, K.A. Bauer, J.H. Morrissey, T.W. Meade, and D.J. Howarth Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease Circulation 102 23 2000 2816 2822